

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPI coating of Golgi vesicle (GO:0048205) | 5.89984980 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 5.89984980 |
| 3 | nuclear pore complex assembly (GO:0051292) | 5.33459063 |
| 4 | nuclear pore organization (GO:0006999) | 4.82429094 |
| 5 | establishment of integrated proviral latency (GO:0075713) | 4.76470455 |
| 6 | DNA unwinding involved in DNA replication (GO:0006268) | 4.49125151 |
| 7 | ribosome assembly (GO:0042255) | 4.32022802 |
| 8 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.23140559 |
| 9 | nucleobase-containing small molecule interconversion (GO:0015949) | 4.20884705 |
| 10 | DNA strand elongation (GO:0022616) | 4.12507073 |
| 11 | oxaloacetate metabolic process (GO:0006107) | 4.10407016 |
| 12 | pore complex assembly (GO:0046931) | 4.09906506 |
| 13 | formation of translation preinitiation complex (GO:0001731) | 4.05103383 |
| 14 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.01660076 |
| 15 | regulation of translational fidelity (GO:0006450) | 3.84327323 |
| 16 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.80915513 |
| 17 | protein localization to chromosome, centromeric region (GO:0071459) | 3.77920641 |
| 18 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.77465386 |
| 19 | mitotic chromosome condensation (GO:0007076) | 3.76768995 |
| 20 | signal peptide processing (GO:0006465) | 3.67449366 |
| 21 | mitotic metaphase plate congression (GO:0007080) | 3.65403759 |
| 22 | establishment of viral latency (GO:0019043) | 3.63267139 |
| 23 | mitotic sister chromatid segregation (GO:0000070) | 3.53725580 |
| 24 | protein localization to kinetochore (GO:0034501) | 3.51302239 |
| 25 | purine nucleobase biosynthetic process (GO:0009113) | 3.49890593 |
| 26 | regulation of translational termination (GO:0006449) | 3.47327760 |
| 27 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.36856015 |
| 28 | NADH metabolic process (GO:0006734) | 3.35190647 |
| 29 | tRNA aminoacylation for protein translation (GO:0006418) | 3.34803650 |
| 30 | negative regulation of microtubule polymerization (GO:0031115) | 3.34415142 |
| 31 | sister chromatid segregation (GO:0000819) | 3.33180961 |
| 32 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.32918376 |
| 33 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.31892072 |
| 34 | response to misfolded protein (GO:0051788) | 3.28212045 |
| 35 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.27481627 |
| 36 | tricarboxylic acid metabolic process (GO:0072350) | 3.26732060 |
| 37 | tRNA aminoacylation (GO:0043039) | 3.25660715 |
| 38 | amino acid activation (GO:0043038) | 3.25660715 |
| 39 | ribosomal small subunit assembly (GO:0000028) | 3.25258296 |
| 40 | DNA replication checkpoint (GO:0000076) | 3.23298992 |
| 41 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.22392655 |
| 42 | telomere maintenance via recombination (GO:0000722) | 3.21916912 |
| 43 | nucleobase biosynthetic process (GO:0046112) | 3.21776234 |
| 44 | IMP biosynthetic process (GO:0006188) | 3.19621721 |
| 45 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.19338862 |
| 46 | IMP metabolic process (GO:0046040) | 3.17539818 |
| 47 | regulation of mitotic spindle organization (GO:0060236) | 3.16414550 |
| 48 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 3.14615059 |
| 49 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.14591806 |
| 50 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.14591806 |
| 51 | DNA replication initiation (GO:0006270) | 3.14374881 |
| 52 | succinate metabolic process (GO:0006105) | 3.14130679 |
| 53 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.10981088 |
| 54 | negative regulation of ligase activity (GO:0051352) | 3.10981088 |
| 55 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.10471395 |
| 56 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.09681320 |
| 57 | mitotic nuclear envelope disassembly (GO:0007077) | 3.07748373 |
| 58 | mitotic recombination (GO:0006312) | 3.05792589 |
| 59 | nuclear envelope reassembly (GO:0031468) | 3.05763277 |
| 60 | mitotic nuclear envelope reassembly (GO:0007084) | 3.05763277 |
| 61 | N-glycan processing (GO:0006491) | 3.05105656 |
| 62 | valine metabolic process (GO:0006573) | 3.03367920 |
| 63 | tricarboxylic acid cycle (GO:0006099) | 3.02622187 |
| 64 | synaptic vesicle exocytosis (GO:0016079) | 3.02508879 |
| 65 | non-recombinational repair (GO:0000726) | 3.01950841 |
| 66 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.01950841 |
| 67 | maturation of SSU-rRNA (GO:0030490) | 2.98996339 |
| 68 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.98693376 |
| 69 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.98693376 |
| 70 | alpha-linolenic acid metabolic process (GO:0036109) | 2.98642744 |
| 71 | ribosome biogenesis (GO:0042254) | 2.94952734 |
| 72 | metaphase plate congression (GO:0051310) | 2.93807256 |
| 73 | DNA ligation (GO:0006266) | 2.93255626 |
| 74 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.92593473 |
| 75 | nucleobase catabolic process (GO:0046113) | 2.92081991 |
| 76 | nuclear envelope disassembly (GO:0051081) | 2.91689511 |
| 77 | membrane disassembly (GO:0030397) | 2.91689511 |
| 78 | virion assembly (GO:0019068) | 2.89918851 |
| 79 | mitotic sister chromatid cohesion (GO:0007064) | 2.87951835 |
| 80 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.87825304 |
| 81 | folic acid metabolic process (GO:0046655) | 2.87695870 |
| 82 | DNA topological change (GO:0006265) | 2.86721380 |
| 83 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.86244188 |
| 84 | response to pheromone (GO:0019236) | 2.85015454 |
| 85 | protein maturation by protein folding (GO:0022417) | 2.84774467 |
| 86 | peptidyl-arginine N-methylation (GO:0035246) | 2.84316862 |
| 87 | peptidyl-arginine methylation (GO:0018216) | 2.84316862 |
| 88 | protein complex localization (GO:0031503) | 2.83049385 |
| 89 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.82050611 |
| 90 | pentose-phosphate shunt (GO:0006098) | 2.81396934 |
| 91 | de novo protein folding (GO:0006458) | 2.77317733 |
| 92 | ribosomal large subunit biogenesis (GO:0042273) | 2.76995094 |
| 93 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.76456549 |
| 94 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.76318033 |
| 95 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.75573207 |
| 96 | vesicle coating (GO:0006901) | 2.75304384 |
| 97 | fucose catabolic process (GO:0019317) | 2.74005354 |
| 98 | L-fucose metabolic process (GO:0042354) | 2.74005354 |
| 99 | L-fucose catabolic process (GO:0042355) | 2.74005354 |
| 100 | mitochondrial fusion (GO:0008053) | 2.73896972 |
| 101 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.73733993 |
| 102 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.73733993 |
| 103 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.72623083 |
| 104 | L-phenylalanine catabolic process (GO:0006559) | 2.72623083 |
| 105 | regulation of synaptic vesicle transport (GO:1902803) | 2.72321167 |
| 106 | DNA duplex unwinding (GO:0032508) | 2.71627625 |
| 107 | proteasome assembly (GO:0043248) | 2.71539034 |
| 108 | establishment of chromosome localization (GO:0051303) | 2.71238907 |
| 109 | protein deneddylation (GO:0000338) | 2.71175666 |
| 110 | NADPH regeneration (GO:0006740) | 2.70577999 |
| 111 | histone H2B ubiquitination (GO:0033523) | 2.70563793 |
| 112 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.70258159 |
| 113 | positive regulation of ligase activity (GO:0051351) | 2.69776633 |
| 114 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.68500415 |
| 115 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.68500415 |
| 116 | viral protein processing (GO:0019082) | 2.67268938 |
| 117 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.67212343 |
| 118 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.67212343 |
| 119 | inositol phosphate catabolic process (GO:0071545) | 2.66434080 |
| 120 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.66143113 |
| 121 | cell cycle G1/S phase transition (GO:0044843) | 2.65178237 |
| 122 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.65178237 |
| 123 | protein retention in ER lumen (GO:0006621) | 2.64854321 |
| 124 | regulation of spindle organization (GO:0090224) | 2.64736203 |
| 125 | de novo posttranslational protein folding (GO:0051084) | 2.64679505 |
| 126 | regulation of translational elongation (GO:0006448) | 2.64665923 |
| 127 | transferrin transport (GO:0033572) | 2.64312020 |
| 128 | regulation of centriole replication (GO:0046599) | 2.63510908 |
| 129 | regulation of mitochondrial translation (GO:0070129) | 2.62918858 |
| 130 | telomere maintenance via telomere lengthening (GO:0010833) | 2.62884395 |
| 131 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.62685510 |
| 132 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.62685510 |
| 133 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.62685510 |
| 134 | COPII vesicle coating (GO:0048208) | 2.61812977 |
| 135 | peroxisome fission (GO:0016559) | 2.61045515 |
| 136 | glutamate secretion (GO:0014047) | 2.61030552 |
| 137 | regulation of oxidative phosphorylation (GO:0002082) | 2.60728002 |
| 138 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.60034191 |
| 139 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.59757571 |
| 140 | 2-oxoglutarate metabolic process (GO:0006103) | 2.58949678 |
| 141 | positive regulation of nuclease activity (GO:0032075) | 2.58214255 |
| 142 | L-phenylalanine metabolic process (GO:0006558) | 2.58157521 |
| 143 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.58157521 |
| 144 | cerebellar Purkinje cell layer development (GO:0021680) | 2.56051778 |
| 145 | cellular ketone body metabolic process (GO:0046950) | 2.54635722 |
| 146 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.54455926 |
| 147 | regulation of autophagic vacuole assembly (GO:2000785) | 2.54024599 |
| 148 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.51620241 |
| 149 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.51562382 |
| 150 | pyrimidine nucleobase metabolic process (GO:0006206) | 2.49462888 |
| 151 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.49405205 |
| 152 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.48942998 |
| 153 | peptidyl-asparagine modification (GO:0018196) | 2.48088327 |
| 154 | gonadal mesoderm development (GO:0007506) | 2.44413369 |
| 155 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.40950071 |
| 156 | necroptotic process (GO:0070266) | 2.39799983 |
| 157 | trivalent inorganic cation transport (GO:0072512) | 2.39495213 |
| 158 | ferric iron transport (GO:0015682) | 2.39495213 |
| 159 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.39458704 |
| 160 | cellular response to interleukin-4 (GO:0071353) | 2.39453830 |
| 161 | beta-amyloid metabolic process (GO:0050435) | 2.39183571 |
| 162 | proline biosynthetic process (GO:0006561) | 2.38584878 |
| 163 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.38423230 |
| 164 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.38127351 |
| 165 | synaptic vesicle maturation (GO:0016188) | 2.36912658 |
| 166 | cullin deneddylation (GO:0010388) | 2.36645477 |
| 167 | galactose catabolic process (GO:0019388) | 2.34515246 |
| 168 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.32798925 |
| 169 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.32495071 |
| 170 | regulation of defense response to virus by virus (GO:0050690) | 2.30564969 |
| 171 | protein N-linked glycosylation (GO:0006487) | 2.29899927 |
| 172 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.28175627 |
| 173 | regulation of synapse structural plasticity (GO:0051823) | 2.27932602 |
| 174 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.27240567 |
| 175 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.26489705 |
| 176 | regulation of nuclease activity (GO:0032069) | 2.26257876 |
| 177 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 2.26006782 |
| 178 | UMP biosynthetic process (GO:0006222) | 2.26006782 |
| 179 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 2.26006782 |
| 180 | UMP metabolic process (GO:0046049) | 2.26006782 |
| 181 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.25693096 |
| 182 | inositol phosphate dephosphorylation (GO:0046855) | 2.25693096 |
| 183 | lysine metabolic process (GO:0006553) | 2.25001773 |
| 184 | lysine catabolic process (GO:0006554) | 2.25001773 |
| 185 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.24345442 |
| 186 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.18933477 |
| 187 | cellular response to topologically incorrect protein (GO:0035967) | 2.15747368 |
| 188 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.15663027 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.91618379 |
| 2 | GATA1_22025678_ChIP-Seq_K562_Human | 3.73968647 |
| 3 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.26258139 |
| 4 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.13232100 |
| 5 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.89623434 |
| 6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.79529658 |
| 7 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.74731451 |
| 8 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.72329639 |
| 9 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.70966087 |
| 10 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.65607745 |
| 11 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.60811152 |
| 12 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.58870204 |
| 13 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.58321441 |
| 14 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.55752021 |
| 15 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.45265543 |
| 16 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.41024761 |
| 17 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.40758183 |
| 18 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.38558947 |
| 19 | MYC_22102868_ChIP-Seq_BL_Human | 2.35123680 |
| 20 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.28734668 |
| 21 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.27141326 |
| 22 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.26789757 |
| 23 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 2.22072523 |
| 24 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.18799814 |
| 25 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.18675992 |
| 26 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.14228211 |
| 27 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.10904585 |
| 28 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.08541320 |
| 29 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.05538954 |
| 30 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.05436781 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.04852060 |
| 32 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.04473364 |
| 33 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.03175655 |
| 34 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.01095305 |
| 35 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 2.00032756 |
| 36 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.95814924 |
| 37 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.95304708 |
| 38 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94004227 |
| 39 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.91523066 |
| 40 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.91232737 |
| 41 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.90634530 |
| 42 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.82619210 |
| 43 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.80916334 |
| 44 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.80800998 |
| 45 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.80277813 |
| 46 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.77947213 |
| 47 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77923128 |
| 48 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.73531369 |
| 49 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.72516604 |
| 50 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.70071393 |
| 51 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.69075457 |
| 52 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.68451583 |
| 53 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.67104787 |
| 54 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.66844235 |
| 55 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.64013025 |
| 56 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.63466064 |
| 57 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.60982676 |
| 58 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.60421590 |
| 59 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.58169956 |
| 60 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.57544572 |
| 61 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.56894885 |
| 62 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.56630691 |
| 63 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.55371830 |
| 64 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.53942464 |
| 65 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.53761667 |
| 66 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.52311890 |
| 67 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.52231739 |
| 68 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.50446805 |
| 69 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.50410358 |
| 70 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.48504535 |
| 71 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.48304007 |
| 72 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.47797139 |
| 73 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.46811962 |
| 74 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46756126 |
| 75 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.46651637 |
| 76 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.46121129 |
| 77 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.45992716 |
| 78 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.45085085 |
| 79 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.41635650 |
| 80 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40175120 |
| 81 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.40126200 |
| 82 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.39699809 |
| 83 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.34510948 |
| 84 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.34207355 |
| 85 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.33626446 |
| 86 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.32622613 |
| 87 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.32156571 |
| 88 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.31388506 |
| 89 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.31094985 |
| 90 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.30859223 |
| 91 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.30476618 |
| 92 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.30469861 |
| 93 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.29840586 |
| 94 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.29706936 |
| 95 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.29192711 |
| 96 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.28911750 |
| 97 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.28664527 |
| 98 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.27445343 |
| 99 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.26875273 |
| 100 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.25016193 |
| 101 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.24165031 |
| 102 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.23428333 |
| 103 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.20600288 |
| 104 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.20245609 |
| 105 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.18499721 |
| 106 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.17437929 |
| 107 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.17277063 |
| 108 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.16391342 |
| 109 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.15634656 |
| 110 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.15167423 |
| 111 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.14977659 |
| 112 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14463555 |
| 113 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.12613760 |
| 114 | UTX_26944678_Chip-Seq_JUKART_Human | 1.12547566 |
| 115 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.12359183 |
| 116 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.11999102 |
| 117 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.11815677 |
| 118 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.11138942 |
| 119 | * EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.11129451 |
| 120 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.11075787 |
| 121 | SPI1_23127762_ChIP-Seq_K562_Human | 1.10905199 |
| 122 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.10386608 |
| 123 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.09743277 |
| 124 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09239827 |
| 125 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 1.08770938 |
| 126 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.07775089 |
| 127 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.07476234 |
| 128 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.06224354 |
| 129 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.05735689 |
| 130 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.05664273 |
| 131 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04088847 |
| 132 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.04003708 |
| 133 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03362063 |
| 134 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.03193918 |
| 135 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02351587 |
| 136 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.01581998 |
| 137 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00846505 |
| 138 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00535667 |
| 139 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.99891829 |
| 140 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.99755447 |
| 141 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99741585 |
| 142 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.99094902 |
| 143 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.98504546 |
| 144 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.98353275 |
| 145 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.97410859 |
| 146 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.95722468 |
| 147 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.94992694 |
| 148 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.94897455 |
| 149 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.94110987 |
| 150 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.93387007 |
| 151 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.87797498 |
| 152 | ATF3_27146783_Chip-Seq_COLON_Human | 0.86795205 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003183_abnormal_peptide_metabolism | 4.27901529 |
| 2 | MP0004957_abnormal_blastocyst_morpholog | 4.24742829 |
| 3 | MP0003693_abnormal_embryo_hatching | 3.87684610 |
| 4 | MP0003111_abnormal_nucleus_morphology | 3.75070856 |
| 5 | MP0010094_abnormal_chromosome_stability | 3.64863794 |
| 6 | MP0002877_abnormal_melanocyte_morpholog | 3.49424745 |
| 7 | MP0003172_abnormal_lysosome_physiology | 3.33210046 |
| 8 | MP0004859_abnormal_synaptic_plasticity | 3.29500142 |
| 9 | MP0003077_abnormal_cell_cycle | 3.16512041 |
| 10 | MP0008932_abnormal_embryonic_tissue | 2.92798317 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.90673893 |
| 12 | MP0005365_abnormal_bile_salt | 2.76619880 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.64904648 |
| 14 | MP0002139_abnormal_hepatobiliary_system | 2.64595868 |
| 15 | MP0008058_abnormal_DNA_repair | 2.58113933 |
| 16 | MP0010352_gastrointestinal_tract_polyps | 2.48601124 |
| 17 | MP0008007_abnormal_cellular_replicative | 2.39375420 |
| 18 | MP0008057_abnormal_DNA_replication | 2.34366966 |
| 19 | MP0009840_abnormal_foam_cell | 2.27403757 |
| 20 | MP0001730_embryonic_growth_arrest | 2.25155145 |
| 21 | MP0010234_abnormal_vibrissa_follicle | 2.16617485 |
| 22 | MP0009697_abnormal_copulation | 2.16233433 |
| 23 | MP0000350_abnormal_cell_proliferation | 2.02977634 |
| 24 | MP0003252_abnormal_bile_duct | 1.96047246 |
| 25 | MP0005360_urolithiasis | 1.94796680 |
| 26 | MP0005085_abnormal_gallbladder_physiolo | 1.93871701 |
| 27 | MP0008875_abnormal_xenobiotic_pharmacok | 1.90344307 |
| 28 | MP0003329_amyloid_beta_deposits | 1.88089928 |
| 29 | MP0003635_abnormal_synaptic_transmissio | 1.87833958 |
| 30 | MP0000537_abnormal_urethra_morphology | 1.87278716 |
| 31 | MP0010329_abnormal_lipoprotein_level | 1.85958453 |
| 32 | MP0004270_analgesia | 1.84115752 |
| 33 | MP0003221_abnormal_cardiomyocyte_apopto | 1.83216746 |
| 34 | MP0002909_abnormal_adrenal_gland | 1.80772503 |
| 35 | MP0001727_abnormal_embryo_implantation | 1.79698144 |
| 36 | MP0003786_premature_aging | 1.78606468 |
| 37 | MP0005220_abnormal_exocrine_pancreas | 1.75200387 |
| 38 | MP0003879_abnormal_hair_cell | 1.73076095 |
| 39 | MP0001672_abnormal_embryogenesis/_devel | 1.72746706 |
| 40 | MP0005380_embryogenesis_phenotype | 1.72746706 |
| 41 | MP0003705_abnormal_hypodermis_morpholog | 1.72217133 |
| 42 | MP0001661_extended_life_span | 1.71918512 |
| 43 | MP0001697_abnormal_embryo_size | 1.70863022 |
| 44 | MP0000604_amyloidosis | 1.70423926 |
| 45 | MP0003566_abnormal_cell_adhesion | 1.69367000 |
| 46 | MP0005501_abnormal_skin_physiology | 1.69138885 |
| 47 | MP0002080_prenatal_lethality | 1.66041076 |
| 48 | MP0003941_abnormal_skin_development | 1.64913257 |
| 49 | MP0003656_abnormal_erythrocyte_physiolo | 1.64239612 |
| 50 | MP0008260_abnormal_autophagy | 1.64156003 |
| 51 | MP0009672_abnormal_birth_weight | 1.62338143 |
| 52 | MP0005083_abnormal_biliary_tract | 1.61720106 |
| 53 | MP0002796_impaired_skin_barrier | 1.61226727 |
| 54 | MP0002063_abnormal_learning/memory/cond | 1.60365218 |
| 55 | MP0001666_abnormal_nutrient_absorption | 1.56877692 |
| 56 | MP0008877_abnormal_DNA_methylation | 1.56750297 |
| 57 | MP0003984_embryonic_growth_retardation | 1.54968917 |
| 58 | MP0002693_abnormal_pancreas_physiology | 1.53009741 |
| 59 | MP0003806_abnormal_nucleotide_metabolis | 1.51755031 |
| 60 | MP0005076_abnormal_cell_differentiation | 1.50789557 |
| 61 | MP0002090_abnormal_vision | 1.50164667 |
| 62 | MP0002084_abnormal_developmental_patter | 1.49806564 |
| 63 | MP0002088_abnormal_embryonic_growth/wei | 1.49676236 |
| 64 | MP0003195_calcinosis | 1.45447299 |
| 65 | MP0002396_abnormal_hematopoietic_system | 1.45401130 |
| 66 | MP0005464_abnormal_platelet_physiology | 1.43739158 |
| 67 | MP0002876_abnormal_thyroid_physiology | 1.42413709 |
| 68 | MP0000490_abnormal_crypts_of | 1.42202675 |
| 69 | MP0006054_spinal_hemorrhage | 1.42104909 |
| 70 | MP0002085_abnormal_embryonic_tissue | 1.40503763 |
| 71 | MP0004185_abnormal_adipocyte_glucose | 1.39127688 |
| 72 | MP0005623_abnormal_meninges_morphology | 1.37300603 |
| 73 | MP0000313_abnormal_cell_death | 1.35209846 |
| 74 | MP0010678_abnormal_skin_adnexa | 1.32331574 |
| 75 | MP0001944_abnormal_pancreas_morphology | 1.31052351 |
| 76 | MP0002837_dystrophic_cardiac_calcinosis | 1.30666331 |
| 77 | MP0002064_seizures | 1.30031430 |
| 78 | MP0002572_abnormal_emotion/affect_behav | 1.30003484 |
| 79 | MP0000013_abnormal_adipose_tissue | 1.29797959 |
| 80 | MP0005408_hypopigmentation | 1.27916163 |
| 81 | MP0009745_abnormal_behavioral_response | 1.27318357 |
| 82 | MP0006036_abnormal_mitochondrial_physio | 1.27075354 |
| 83 | MP0000579_abnormal_nail_morphology | 1.26517549 |
| 84 | MP0002009_preneoplasia | 1.25595839 |
| 85 | MP0003880_abnormal_central_pattern | 1.24585688 |
| 86 | MP0002078_abnormal_glucose_homeostasis | 1.23856441 |
| 87 | MP0001764_abnormal_homeostasis | 1.21310729 |
| 88 | MP0004782_abnormal_surfactant_physiolog | 1.21097559 |
| 89 | MP0002086_abnormal_extraembryonic_tissu | 1.20927602 |
| 90 | MP0004197_abnormal_fetal_growth/weight/ | 1.20728696 |
| 91 | MP0005636_abnormal_mineral_homeostasis | 1.20431237 |
| 92 | MP0003868_abnormal_feces_composition | 1.20422860 |
| 93 | MP0005332_abnormal_amino_acid | 1.18623805 |
| 94 | MP0004043_abnormal_pH_regulation | 1.18328025 |
| 95 | MP0000358_abnormal_cell_content/ | 1.17324123 |
| 96 | MP0004272_abnormal_basement_membrane | 1.17153451 |
| 97 | MP0001765_abnormal_ion_homeostasis | 1.16606029 |
| 98 | MP0002098_abnormal_vibrissa_morphology | 1.15447032 |
| 99 | MP0002736_abnormal_nociception_after | 1.14916136 |
| 100 | MP0006035_abnormal_mitochondrial_morpho | 1.14251697 |
| 101 | MP0003315_abnormal_perineum_morphology | 1.13868345 |
| 102 | MP0010307_abnormal_tumor_latency | 1.13716177 |
| 103 | MP0003718_maternal_effect | 1.12820732 |
| 104 | MP0002697_abnormal_eye_size | 1.11354196 |
| 105 | MP0002735_abnormal_chemical_nociception | 1.10868387 |
| 106 | MP0010386_abnormal_urinary_bladder | 1.10191029 |
| 107 | MP0005248_abnormal_Harderian_gland | 1.10166212 |
| 108 | MP0000377_abnormal_hair_follicle | 1.09679759 |
| 109 | MP0009643_abnormal_urine_homeostasis | 1.09533595 |
| 110 | MP0000609_abnormal_liver_physiology | 1.09127176 |
| 111 | MP0002118_abnormal_lipid_homeostasis | 1.08863183 |
| 112 | MP0005384_cellular_phenotype | 1.08618619 |
| 113 | MP0010030_abnormal_orbit_morphology | 1.07565225 |
| 114 | MP0001216_abnormal_epidermal_layer | 1.07512162 |
| 115 | MP0003763_abnormal_thymus_physiology | 1.07321382 |
| 116 | MP0004811_abnormal_neuron_physiology | 1.05797005 |
| 117 | MP0005621_abnormal_cell_physiology | 1.05730151 |
| 118 | MP0009703_decreased_birth_body | 1.04269714 |
| 119 | MP0008961_abnormal_basal_metabolism | 1.03157847 |
| 120 | MP0005319_abnormal_enzyme/_coenzyme | 1.01241065 |
| 121 | MP0003866_abnormal_defecation | 1.01040671 |
| 122 | MP0009053_abnormal_anal_canal | 1.00620131 |
| 123 | MP0000627_abnormal_mammary_gland | 1.00271659 |
| 124 | MP0001835_abnormal_antigen_presentation | 1.00131440 |
| 125 | MP0005671_abnormal_response_to | 0.98371698 |
| 126 | MP0001346_abnormal_lacrimal_gland | 0.98058528 |
| 127 | MP0001873_stomach_inflammation | 0.97953477 |
| 128 | MP0009780_abnormal_chondrocyte_physiolo | 0.97343058 |
| 129 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.96669328 |
| 130 | MP0001968_abnormal_touch/_nociception | 0.96669157 |
| 131 | MP0001849_ear_inflammation | 0.96200405 |
| 132 | MP0003690_abnormal_glial_cell | 0.95758168 |
| 133 | MP0003075_altered_response_to | 0.95630216 |
| 134 | MP0002234_abnormal_pharynx_morphology | 0.95059543 |
| 135 | MP0002272_abnormal_nervous_system | 0.94521315 |
| 136 | MP0001529_abnormal_vocalization | 0.93637490 |
| 137 | MP0008469_abnormal_protein_level | 0.92877491 |
| 138 | MP0000647_abnormal_sebaceous_gland | 0.90505530 |
| 139 | MP0002060_abnormal_skin_morphology | 0.90250917 |
| 140 | MP0003186_abnormal_redox_activity | 0.89949616 |
| 141 | MP0000465_gastrointestinal_hemorrhage | 0.89195084 |
| 142 | MP0004947_skin_inflammation | 0.88849752 |
| 143 | MP0000689_abnormal_spleen_morphology | 0.88628728 |
| 144 | MP0001881_abnormal_mammary_gland | 0.88578942 |
| 145 | MP0000678_abnormal_parathyroid_gland | 0.88194091 |
| 146 | MP0005451_abnormal_body_composition | 0.87952259 |
| 147 | MP0003436_decreased_susceptibility_to | 0.87847084 |
| 148 | MP0002160_abnormal_reproductive_system | 0.87141793 |
| 149 | MP0002419_abnormal_innate_immunity | 0.86914086 |
| 150 | MP0000747_muscle_weakness | 0.86610419 |
| 151 | MP0002928_abnormal_bile_duct | 0.86567003 |
| 152 | MP0002398_abnormal_bone_marrow | 0.86396964 |
| 153 | MP0002269_muscular_atrophy | 0.86273270 |
| 154 | MP0004147_increased_porphyrin_level | 0.85547956 |
| 155 | MP0005535_abnormal_body_temperature | 0.85044619 |
| 156 | MP0002734_abnormal_mechanical_nocicepti | 0.84464876 |
| 157 | MP0009642_abnormal_blood_homeostasis | 0.84407541 |
| 158 | MP0004233_abnormal_muscle_weight | 0.83202132 |
| 159 | MP0002420_abnormal_adaptive_immunity | 0.83020514 |
| 160 | MP0003937_abnormal_limbs/digits/tail_de | 0.82416484 |
| 161 | MP0004264_abnormal_extraembryonic_tissu | 0.82145750 |
| 162 | MP0002111_abnormal_tail_morphology | 0.81929248 |
| 163 | MP0002092_abnormal_eye_morphology | 0.80712851 |
| 164 | MP0005187_abnormal_penis_morphology | 0.80451939 |
| 165 | MP0003953_abnormal_hormone_level | 0.80400712 |
| 166 | MP0005448_abnormal_energy_balance | 0.80399781 |
| 167 | MP0001819_abnormal_immune_cell | 0.80358843 |
| 168 | MP0002067_abnormal_sensory_capabilities | 0.80214860 |
| 169 | MP0002557_abnormal_social/conspecific_i | 0.80022076 |
| 170 | MP0003453_abnormal_keratinocyte_physiol | 0.79723599 |
| 171 | MP0002229_neurodegeneration | 0.78470459 |
| 172 | MP0008874_decreased_physiological_sensi | 0.78000013 |
| 173 | MP0001243_abnormal_dermal_layer | 0.76770320 |
| 174 | MP0000762_abnormal_tongue_morphology | 0.76715122 |
| 175 | MP0002722_abnormal_immune_system | 0.76283705 |
| 176 | MP0002733_abnormal_thermal_nociception | 0.75345023 |
| 177 | MP0001845_abnormal_inflammatory_respons | 0.75145908 |
| 178 | MP0000598_abnormal_liver_morphology | 0.74618986 |
| 179 | MP0006276_abnormal_autonomic_nervous | 0.73941501 |
| 180 | MP0002019_abnormal_tumor_incidence | 0.73420744 |
| 181 | MP0002429_abnormal_blood_cell | 0.72558080 |
| 182 | MP0010771_integument_phenotype | 0.70292314 |
| 183 | MP0002233_abnormal_nose_morphology | 0.69365125 |
| 184 | MP0000383_abnormal_hair_follicle | 0.68914799 |
| 185 | MP0001293_anophthalmia | 0.68643424 |
| 186 | MP0003123_paternal_imprinting | 0.68208550 |
| 187 | MP0000477_abnormal_intestine_morphology | 0.64961702 |
| 188 | MP0000427_abnormal_hair_cycle | 0.64903510 |
| 189 | MP0003385_abnormal_body_wall | 0.64589398 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Papilledema (HP:0001085) | 3.78204718 |
| 2 | Abnormality of glycolysis (HP:0004366) | 3.73416603 |
| 3 | Vacuolated lymphocytes (HP:0001922) | 3.64811662 |
| 4 | Increased serum pyruvate (HP:0003542) | 3.43225900 |
| 5 | Dysostosis multiplex (HP:0000943) | 3.35799345 |
| 6 | Insidious onset (HP:0003587) | 3.28648561 |
| 7 | Termporal pattern (HP:0011008) | 3.28648561 |
| 8 | Ketoacidosis (HP:0001993) | 3.22485645 |
| 9 | Selective tooth agenesis (HP:0001592) | 3.14279614 |
| 10 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.13846106 |
| 11 | Mucopolysacchariduria (HP:0008155) | 3.09788127 |
| 12 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.09788127 |
| 13 | Increased cerebral lipofuscin (HP:0011813) | 3.04482658 |
| 14 | Abnormality of the anterior horn cell (HP:0006802) | 2.98436272 |
| 15 | Degeneration of anterior horn cells (HP:0002398) | 2.98436272 |
| 16 | Abnormality of glycolipid metabolism (HP:0010969) | 2.97609974 |
| 17 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.97609974 |
| 18 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.97609974 |
| 19 | Agnosia (HP:0010524) | 2.94237014 |
| 20 | Cortical dysplasia (HP:0002539) | 2.93582007 |
| 21 | Chromsome breakage (HP:0040012) | 2.93494639 |
| 22 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.91010391 |
| 23 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.91010391 |
| 24 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.91010391 |
| 25 | Thrombocytosis (HP:0001894) | 2.87260890 |
| 26 | Ketosis (HP:0001946) | 2.87033098 |
| 27 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.86527113 |
| 28 | Visual hallucinations (HP:0002367) | 2.86308241 |
| 29 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.79208734 |
| 30 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.75303212 |
| 31 | Progressive muscle weakness (HP:0003323) | 2.70933757 |
| 32 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.59286317 |
| 33 | Unilateral renal agenesis (HP:0000122) | 2.58001355 |
| 34 | Spastic diplegia (HP:0001264) | 2.54423404 |
| 35 | Neuroendocrine neoplasm (HP:0100634) | 2.51020842 |
| 36 | J-shaped sella turcica (HP:0002680) | 2.50678670 |
| 37 | Multiple enchondromatosis (HP:0005701) | 2.47370770 |
| 38 | Generalized aminoaciduria (HP:0002909) | 2.46709228 |
| 39 | Large eyes (HP:0001090) | 2.45634106 |
| 40 | Type I transferrin isoform profile (HP:0003642) | 2.43146860 |
| 41 | Asymmetry of the thorax (HP:0001555) | 2.42821653 |
| 42 | Pheochromocytoma (HP:0002666) | 2.41579843 |
| 43 | Conjugated hyperbilirubinemia (HP:0002908) | 2.39395131 |
| 44 | Overlapping toe (HP:0001845) | 2.37014792 |
| 45 | Abnormality of the lower motor neuron (HP:0002366) | 2.36832953 |
| 46 | Aplastic anemia (HP:0001915) | 2.32614739 |
| 47 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.32140993 |
| 48 | IgM deficiency (HP:0002850) | 2.31402623 |
| 49 | Hypokinesia (HP:0002375) | 2.30323702 |
| 50 | Deviation of the thumb (HP:0009603) | 2.30099732 |
| 51 | Microvesicular hepatic steatosis (HP:0001414) | 2.29585670 |
| 52 | Microglossia (HP:0000171) | 2.29520179 |
| 53 | Progressive neurologic deterioration (HP:0002344) | 2.27997907 |
| 54 | Cutaneous melanoma (HP:0012056) | 2.27499251 |
| 55 | Abnormality of the umbilical cord (HP:0010881) | 2.24396615 |
| 56 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.22324509 |
| 57 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.22324509 |
| 58 | Proximal placement of thumb (HP:0009623) | 2.22170054 |
| 59 | Increased nuchal translucency (HP:0010880) | 2.21735390 |
| 60 | Epileptiform EEG discharges (HP:0011182) | 2.20934699 |
| 61 | Birth length less than 3rd percentile (HP:0003561) | 2.20699272 |
| 62 | Ankyloglossia (HP:0010296) | 2.20136049 |
| 63 | Deep philtrum (HP:0002002) | 2.19552584 |
| 64 | Septate vagina (HP:0001153) | 2.17930144 |
| 65 | Sparse eyelashes (HP:0000653) | 2.17719177 |
| 66 | Rough bone trabeculation (HP:0100670) | 2.17108285 |
| 67 | Orthostatic hypotension (HP:0001278) | 2.16567146 |
| 68 | EEG with generalized epileptiform discharges (HP:0011198) | 2.13570231 |
| 69 | Abnormality of oral frenula (HP:0000190) | 2.12690446 |
| 70 | Abnormal protein glycosylation (HP:0012346) | 2.12133419 |
| 71 | Abnormal glycosylation (HP:0012345) | 2.12133419 |
| 72 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.12133419 |
| 73 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.12133419 |
| 74 | Abnormal gallbladder physiology (HP:0012438) | 2.11669932 |
| 75 | Cholecystitis (HP:0001082) | 2.11669932 |
| 76 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.11115825 |
| 77 | Abnormality of the motor neurons (HP:0002450) | 2.10976732 |
| 78 | Abnormal neuron morphology (HP:0012757) | 2.10976732 |
| 79 | Trismus (HP:0000211) | 2.07893216 |
| 80 | Abnormality of methionine metabolism (HP:0010901) | 2.07728828 |
| 81 | Amyotrophic lateral sclerosis (HP:0007354) | 2.07663169 |
| 82 | Short middle phalanx of the 5th finger (HP:0004220) | 2.07635294 |
| 83 | Hypsarrhythmia (HP:0002521) | 2.07532004 |
| 84 | Epileptic encephalopathy (HP:0200134) | 2.06626361 |
| 85 | Micronodular cirrhosis (HP:0001413) | 2.06530139 |
| 86 | Fasciculations (HP:0002380) | 2.06090678 |
| 87 | Abnormal platelet function (HP:0011869) | 2.04488179 |
| 88 | Impaired platelet aggregation (HP:0003540) | 2.04488179 |
| 89 | * Late onset (HP:0003584) | 2.03137731 |
| 90 | Glomerulonephritis (HP:0000099) | 2.02374247 |
| 91 | Limb hypertonia (HP:0002509) | 2.01953740 |
| 92 | Increased hepatocellular lipid droplets (HP:0006565) | 2.01440804 |
| 93 | Hepatic necrosis (HP:0002605) | 2.01172181 |
| 94 | Gout (HP:0001997) | 2.00906783 |
| 95 | Hepatocellular necrosis (HP:0001404) | 2.00237395 |
| 96 | Disinhibition (HP:0000734) | 2.00115290 |
| 97 | Short nail (HP:0001799) | 1.98332900 |
| 98 | Upper motor neuron abnormality (HP:0002127) | 1.98151935 |
| 99 | Progressive external ophthalmoplegia (HP:0000590) | 1.97242445 |
| 100 | Hypoglycemic coma (HP:0001325) | 1.95772820 |
| 101 | Increased intramyocellular lipid droplets (HP:0012240) | 1.95408112 |
| 102 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.94813946 |
| 103 | Proximal tubulopathy (HP:0000114) | 1.94469417 |
| 104 | Macrocytic anemia (HP:0001972) | 1.93634168 |
| 105 | Hyperbilirubinemia (HP:0002904) | 1.93521133 |
| 106 | Death in childhood (HP:0003819) | 1.93392598 |
| 107 | Abnormality of the intrinsic pathway (HP:0010989) | 1.92411560 |
| 108 | Poor suck (HP:0002033) | 1.91439323 |
| 109 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.91213350 |
| 110 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.91213350 |
| 111 | Single umbilical artery (HP:0001195) | 1.91213350 |
| 112 | Insomnia (HP:0100785) | 1.88615331 |
| 113 | Missing ribs (HP:0000921) | 1.87449519 |
| 114 | Abnormal eating behavior (HP:0100738) | 1.87434214 |
| 115 | Retinal atrophy (HP:0001105) | 1.86721555 |
| 116 | Shoulder girdle muscle weakness (HP:0003547) | 1.86041936 |
| 117 | Polyphagia (HP:0002591) | 1.84503221 |
| 118 | Muscular hypotonia of the trunk (HP:0008936) | 1.84206010 |
| 119 | Neoplasm of the adrenal gland (HP:0100631) | 1.84070920 |
| 120 | Postnatal microcephaly (HP:0005484) | 1.82431900 |
| 121 | Posterior subcapsular cataract (HP:0007787) | 1.81789258 |
| 122 | Abnormality of nail color (HP:0100643) | 1.81722166 |
| 123 | Conjunctival hamartoma (HP:0100780) | 1.81210954 |
| 124 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.80208123 |
| 125 | Abnormality of the common coagulation pathway (HP:0010990) | 1.79573564 |
| 126 | Ridged nail (HP:0001807) | 1.79469978 |
| 127 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.78480859 |
| 128 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.78435949 |
| 129 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.78435949 |
| 130 | Secondary amenorrhea (HP:0000869) | 1.78347173 |
| 131 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.78157177 |
| 132 | Ragged-red muscle fibers (HP:0003200) | 1.77723063 |
| 133 | Breech presentation (HP:0001623) | 1.77485340 |
| 134 | Hypoparathyroidism (HP:0000829) | 1.77424309 |
| 135 | Atonic seizures (HP:0010819) | 1.77257858 |
| 136 | Absence seizures (HP:0002121) | 1.76969785 |
| 137 | Tinnitus (HP:0000360) | 1.76615975 |
| 138 | Death in infancy (HP:0001522) | 1.76116456 |
| 139 | Akinesia (HP:0002304) | 1.74948605 |
| 140 | Lipid accumulation in hepatocytes (HP:0006561) | 1.74824446 |
| 141 | Testicular atrophy (HP:0000029) | 1.74336042 |
| 142 | Agitation (HP:0000713) | 1.73919471 |
| 143 | Pelvic girdle muscle weakness (HP:0003749) | 1.73784320 |
| 144 | Gonadotropin excess (HP:0000837) | 1.73408504 |
| 145 | Cerebral palsy (HP:0100021) | 1.73277813 |
| 146 | High anterior hairline (HP:0009890) | 1.73188354 |
| 147 | Hyperacusis (HP:0010780) | 1.71906430 |
| 148 | 11 pairs of ribs (HP:0000878) | 1.71454899 |
| 149 | Squamous cell carcinoma (HP:0002860) | 1.70864730 |
| 150 | Recurrent bacterial skin infections (HP:0005406) | 1.70607705 |
| 151 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.68983141 |
| 152 | Thyroid carcinoma (HP:0002890) | 1.68941823 |
| 153 | Hyperlipoproteinemia (HP:0010980) | 1.68888300 |
| 154 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.68106612 |
| 155 | Reticulocytosis (HP:0001923) | 1.67981840 |
| 156 | Abnormality of the tricuspid valve (HP:0001702) | 1.67849362 |
| 157 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.67720089 |
| 158 | Amniotic constriction ring (HP:0009775) | 1.67603058 |
| 159 | Abnormality of placental membranes (HP:0011409) | 1.67603058 |
| 160 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.66907642 |
| 161 | Pili torti (HP:0003777) | 1.66763475 |
| 162 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.66569780 |
| 163 | Abnormality of the preputium (HP:0100587) | 1.66516640 |
| 164 | Cortical visual impairment (HP:0100704) | 1.66361571 |
| 165 | Generalized tonic-clonic seizures (HP:0002069) | 1.66053380 |
| 166 | Abnormal trabecular bone morphology (HP:0100671) | 1.65516792 |
| 167 | Papillary thyroid carcinoma (HP:0002895) | 1.65132612 |
| 168 | Cardiomegaly (HP:0001640) | 1.63507277 |
| 169 | Abnormality of chromosome stability (HP:0003220) | 1.63361477 |
| 170 | Irritability (HP:0000737) | 1.63062038 |
| 171 | Abnormality of reticulocytes (HP:0004312) | 1.62954947 |
| 172 | Severe visual impairment (HP:0001141) | 1.62767848 |
| 173 | Facial cleft (HP:0002006) | 1.62226433 |
| 174 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.61992109 |
| 175 | Upper limb muscle weakness (HP:0003484) | 1.61720926 |
| 176 | Hypoplasia of the pons (HP:0012110) | 1.61496176 |
| 177 | Progressive microcephaly (HP:0000253) | 1.61307770 |
| 178 | Apathy (HP:0000741) | 1.60622609 |
| 179 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.59555572 |
| 180 | Protuberant abdomen (HP:0001538) | 1.59553063 |
| 181 | Megaloblastic anemia (HP:0001889) | 1.59056089 |
| 182 | Myelodysplasia (HP:0002863) | 1.58469213 |
| 183 | Severe short stature (HP:0003510) | 1.58268408 |
| 184 | Lower limb hyperreflexia (HP:0002395) | 1.58003042 |
| 185 | Autoamputation (HP:0001218) | 1.57445971 |
| 186 | Delayed CNS myelination (HP:0002188) | 1.57318210 |
| 187 | Hypobetalipoproteinemia (HP:0003563) | 1.57002208 |
| 188 | Pancytopenia (HP:0001876) | 1.56801733 |
| 189 | Overriding aorta (HP:0002623) | 1.56394799 |
| 190 | Lactic acidosis (HP:0003128) | 1.56228660 |
| 191 | Depression (HP:0000716) | 1.56223450 |
| 192 | Progressive hearing impairment (HP:0001730) | 1.56108934 |
| 193 | Diminished motivation (HP:0000745) | 1.56004595 |
| 194 | Craniofacial dystonia (HP:0012179) | 1.55889453 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EIF2AK1 | 3.91811084 |
| 2 | BUB1 | 3.48417093 |
| 3 | PBK | 3.14291637 |
| 4 | TTK | 2.93993302 |
| 5 | CAMKK2 | 2.80043361 |
| 6 | MAP3K9 | 2.67084606 |
| 7 | FLT3 | 2.48437158 |
| 8 | SCYL2 | 2.48183663 |
| 9 | NEK1 | 2.36886436 |
| 10 | NTRK3 | 2.36612300 |
| 11 | PKN2 | 2.34511577 |
| 12 | CCNB1 | 2.23881386 |
| 13 | ERN1 | 2.13166340 |
| 14 | BCKDK | 2.08719258 |
| 15 | TAOK3 | 2.08713883 |
| 16 | NME2 | 2.07848192 |
| 17 | DAPK1 | 2.07741038 |
| 18 | KIT | 2.06927774 |
| 19 | EEF2K | 2.02500968 |
| 20 | MINK1 | 2.00849283 |
| 21 | EPHA2 | 2.00651855 |
| 22 | MST1R | 2.00634427 |
| 23 | DAPK2 | 1.97938419 |
| 24 | MARK1 | 1.97204356 |
| 25 | IRAK3 | 1.83942297 |
| 26 | BCR | 1.82013704 |
| 27 | RPS6KA4 | 1.80908197 |
| 28 | MAP3K12 | 1.80387294 |
| 29 | PASK | 1.77809212 |
| 30 | CDK19 | 1.70031592 |
| 31 | MST4 | 1.68996993 |
| 32 | PRPF4B | 1.63074669 |
| 33 | CAMKK1 | 1.55115584 |
| 34 | ACVR1B | 1.54454518 |
| 35 | BTK | 1.48249061 |
| 36 | TSSK6 | 1.48196018 |
| 37 | SYK | 1.45979273 |
| 38 | LATS2 | 1.43632815 |
| 39 | WEE1 | 1.41818481 |
| 40 | SMG1 | 1.39196995 |
| 41 | MAP2K3 | 1.38945550 |
| 42 | ITK | 1.38808965 |
| 43 | TGFBR1 | 1.37295311 |
| 44 | TGFBR2 | 1.29480326 |
| 45 | TEC | 1.27955954 |
| 46 | CDK12 | 1.25889162 |
| 47 | TRIM28 | 1.24829337 |
| 48 | MET | 1.23345983 |
| 49 | CSF1R | 1.19435329 |
| 50 | VRK2 | 1.18360485 |
| 51 | PLK3 | 1.16675520 |
| 52 | MAP3K13 | 1.16527965 |
| 53 | KSR2 | 1.15738011 |
| 54 | CDK7 | 1.15267073 |
| 55 | FES | 1.14460133 |
| 56 | CLK1 | 1.12767827 |
| 57 | MAPKAPK3 | 1.10458184 |
| 58 | ZAP70 | 1.10304417 |
| 59 | AURKB | 1.08785043 |
| 60 | EIF2AK3 | 1.08767333 |
| 61 | PLK1 | 1.07588943 |
| 62 | ARAF | 1.05250961 |
| 63 | PDK3 | 1.04021233 |
| 64 | PDK4 | 1.04021233 |
| 65 | ALK | 1.03692870 |
| 66 | MAPK13 | 1.03531780 |
| 67 | GRK6 | 1.01958891 |
| 68 | MAP2K7 | 0.99914686 |
| 69 | CDK9 | 0.99897000 |
| 70 | ATR | 0.97139759 |
| 71 | MAP2K4 | 0.96473418 |
| 72 | CHEK2 | 0.95346456 |
| 73 | BRSK1 | 0.92394938 |
| 74 | CDC7 | 0.87823947 |
| 75 | ERBB3 | 0.84388027 |
| 76 | PIK3CG | 0.83881111 |
| 77 | EPHA4 | 0.83836242 |
| 78 | ILK | 0.83073202 |
| 79 | KSR1 | 0.83001973 |
| 80 | CHEK1 | 0.82918019 |
| 81 | RPS6KA2 | 0.80895253 |
| 82 | SRPK1 | 0.80702242 |
| 83 | CDK5 | 0.77659268 |
| 84 | TYK2 | 0.75923481 |
| 85 | MKNK1 | 0.75696287 |
| 86 | TRIB3 | 0.75334514 |
| 87 | MAP4K1 | 0.74737845 |
| 88 | JAK2 | 0.74521472 |
| 89 | CDK18 | 0.74147484 |
| 90 | CDK8 | 0.74080968 |
| 91 | GRK5 | 0.74063004 |
| 92 | LIMK1 | 0.74059034 |
| 93 | BRAF | 0.73228224 |
| 94 | MOS | 0.71643272 |
| 95 | MAP3K8 | 0.71410269 |
| 96 | MAP3K4 | 0.71232881 |
| 97 | PDK1 | 0.70876226 |
| 98 | STK16 | 0.70788622 |
| 99 | CDK15 | 0.69259146 |
| 100 | BRSK2 | 0.67945724 |
| 101 | INSRR | 0.67088557 |
| 102 | CSNK1G3 | 0.67033828 |
| 103 | LATS1 | 0.66906780 |
| 104 | RPS6KB1 | 0.66280842 |
| 105 | PDK2 | 0.65709377 |
| 106 | ERBB4 | 0.64902991 |
| 107 | AKT2 | 0.63194830 |
| 108 | SGK2 | 0.62949896 |
| 109 | CDK11A | 0.62800287 |
| 110 | UHMK1 | 0.62492862 |
| 111 | PLK4 | 0.61141535 |
| 112 | NME1 | 0.60820909 |
| 113 | TESK1 | 0.60502370 |
| 114 | TESK2 | 0.60435354 |
| 115 | CSNK1A1L | 0.60390896 |
| 116 | CDK6 | 0.57644218 |
| 117 | MAP2K6 | 0.57593991 |
| 118 | ICK | 0.57346608 |
| 119 | CDK14 | 0.55714849 |
| 120 | NEK6 | 0.55599131 |
| 121 | MAP3K1 | 0.54345287 |
| 122 | MAP3K6 | 0.54056029 |
| 123 | PAK4 | 0.53066636 |
| 124 | FGFR4 | 0.52827400 |
| 125 | RET | 0.52682518 |
| 126 | AURKA | 0.52086236 |
| 127 | EIF2AK2 | 0.52000308 |
| 128 | MAPK4 | 0.51457207 |
| 129 | PDGFRA | 0.50947820 |
| 130 | ATM | 0.50251952 |
| 131 | CASK | 0.48713213 |
| 132 | VRK1 | 0.48550539 |
| 133 | CSNK2A2 | 0.48433551 |
| 134 | BRD4 | 0.47819589 |
| 135 | MAPK11 | 0.47527379 |
| 136 | SIK3 | 0.47354641 |
| 137 | GRK7 | 0.46965359 |
| 138 | PTK6 | 0.46689215 |
| 139 | NTRK2 | 0.45396727 |
| 140 | LCK | 0.45125988 |
| 141 | MAP3K10 | 0.45046995 |
| 142 | PLK2 | 0.45012114 |
| 143 | LYN | 0.44682006 |
| 144 | SGK3 | 0.43755052 |
| 145 | RPS6KA5 | 0.43588811 |
| 146 | CDK1 | 0.43472034 |
| 147 | MAPK12 | 0.42748334 |
| 148 | NTRK1 | 0.42740333 |
| 149 | CDK4 | 0.42078581 |
| 150 | RPS6KB2 | 0.41645746 |
| 151 | CDK2 | 0.41087606 |
| 152 | CSNK2A1 | 0.40936857 |
| 153 | ZAK | 0.40911772 |
| 154 | RAF1 | 0.40728705 |
| 155 | MAP3K2 | 0.40399699 |
| 156 | SGK494 | 0.40319398 |
| 157 | SGK223 | 0.40319398 |
| 158 | PTK2 | 0.39807226 |
| 159 | CSNK1G1 | 0.39565966 |
| 160 | STK4 | 0.37997780 |
| 161 | TTN | 0.37213266 |
| 162 | PRKCI | 0.37096638 |
| 163 | CSNK1E | 0.36961832 |
| 164 | PNCK | 0.36885025 |
| 165 | DYRK3 | 0.35345534 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.88889337 |
| 2 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 3.09393350 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.90960389 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.73164116 |
| 5 | Spliceosome_Homo sapiens_hsa03040 | 2.59315435 |
| 6 | Protein export_Homo sapiens_hsa03060 | 2.55756745 |
| 7 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.48590458 |
| 8 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.47080154 |
| 9 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.44539330 |
| 10 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.42085208 |
| 11 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.33897831 |
| 12 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.29953887 |
| 13 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.29279059 |
| 14 | RNA transport_Homo sapiens_hsa03013 | 2.24164066 |
| 15 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.24094675 |
| 16 | Cell cycle_Homo sapiens_hsa04110 | 2.14704441 |
| 17 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.11646773 |
| 18 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.96630846 |
| 19 | Base excision repair_Homo sapiens_hsa03410 | 1.92585276 |
| 20 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.90963364 |
| 21 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.90822460 |
| 22 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.87463630 |
| 23 | Lysosome_Homo sapiens_hsa04142 | 1.81855979 |
| 24 | Ribosome_Homo sapiens_hsa03010 | 1.72778962 |
| 25 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.72277498 |
| 26 | Homologous recombination_Homo sapiens_hsa03440 | 1.65251045 |
| 27 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.53853184 |
| 28 | RNA polymerase_Homo sapiens_hsa03020 | 1.53539634 |
| 29 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.51709486 |
| 30 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.50061942 |
| 31 | Carbon metabolism_Homo sapiens_hsa01200 | 1.49534444 |
| 32 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.49023899 |
| 33 | DNA replication_Homo sapiens_hsa03030 | 1.46672444 |
| 34 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.46477108 |
| 35 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.42024377 |
| 36 | Long-term potentiation_Homo sapiens_hsa04720 | 1.40616181 |
| 37 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.34253425 |
| 38 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.33242253 |
| 39 | Insulin secretion_Homo sapiens_hsa04911 | 1.30499895 |
| 40 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.27514817 |
| 41 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.22889627 |
| 42 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.19670439 |
| 43 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.19045308 |
| 44 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.18401462 |
| 45 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.18043855 |
| 46 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.07717525 |
| 47 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.07216655 |
| 48 | Basal transcription factors_Homo sapiens_hsa03022 | 1.05903771 |
| 49 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.05670280 |
| 50 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.04721395 |
| 51 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.03717520 |
| 52 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.01741562 |
| 53 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.00712475 |
| 54 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.99977314 |
| 55 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.99494882 |
| 56 | Nicotine addiction_Homo sapiens_hsa05033 | 0.99017451 |
| 57 | RNA degradation_Homo sapiens_hsa03018 | 0.98195347 |
| 58 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.96750873 |
| 59 | Olfactory transduction_Homo sapiens_hsa04740 | 0.95979399 |
| 60 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.95422882 |
| 61 | Circadian entrainment_Homo sapiens_hsa04713 | 0.94992219 |
| 62 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.94818887 |
| 63 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.94348814 |
| 64 | Huntingtons disease_Homo sapiens_hsa05016 | 0.93998328 |
| 65 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.93601556 |
| 66 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.93592029 |
| 67 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.93199609 |
| 68 | Phagosome_Homo sapiens_hsa04145 | 0.91226691 |
| 69 | Purine metabolism_Homo sapiens_hsa00230 | 0.87230635 |
| 70 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.86813119 |
| 71 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.86668392 |
| 72 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.85805872 |
| 73 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.84914354 |
| 74 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.84334333 |
| 75 | GABAergic synapse_Homo sapiens_hsa04727 | 0.82957902 |
| 76 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.79669752 |
| 77 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.79135135 |
| 78 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.78942349 |
| 79 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.78113552 |
| 80 | Adherens junction_Homo sapiens_hsa04520 | 0.77221796 |
| 81 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.75637673 |
| 82 | Peroxisome_Homo sapiens_hsa04146 | 0.75248934 |
| 83 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.75209847 |
| 84 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.75080732 |
| 85 | Proteasome_Homo sapiens_hsa03050 | 0.74598137 |
| 86 | Galactose metabolism_Homo sapiens_hsa00052 | 0.73278632 |
| 87 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.73169953 |
| 88 | Mismatch repair_Homo sapiens_hsa03430 | 0.73155562 |
| 89 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71925598 |
| 90 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.71736430 |
| 91 | Sulfur relay system_Homo sapiens_hsa04122 | 0.71082737 |
| 92 | Shigellosis_Homo sapiens_hsa05131 | 0.69824331 |
| 93 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.68947623 |
| 94 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.68812077 |
| 95 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.68064033 |
| 96 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.67757818 |
| 97 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.66545869 |
| 98 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.65641500 |
| 99 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.65050485 |
| 100 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.63421011 |
| 101 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62400099 |
| 102 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.61635878 |
| 103 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.60909456 |
| 104 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.60366150 |
| 105 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.59360800 |
| 106 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.59315285 |
| 107 | Bladder cancer_Homo sapiens_hsa05219 | 0.58174497 |
| 108 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.57389611 |
| 109 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.56307101 |
| 110 | Renin secretion_Homo sapiens_hsa04924 | 0.56171793 |
| 111 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.53848617 |
| 112 | Alcoholism_Homo sapiens_hsa05034 | 0.53115621 |
| 113 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.53036602 |
| 114 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.49812954 |
| 115 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.48096980 |
| 116 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.47143061 |
| 117 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.46701722 |
| 118 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.45726753 |
| 119 | ABC transporters_Homo sapiens_hsa02010 | 0.45408282 |
| 120 | Morphine addiction_Homo sapiens_hsa05032 | 0.45170738 |
| 121 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.44357480 |
| 122 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.43998001 |
| 123 | Alzheimers disease_Homo sapiens_hsa05010 | 0.43915764 |
| 124 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.42945650 |
| 125 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.42269243 |
| 126 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.41612231 |
| 127 | Parkinsons disease_Homo sapiens_hsa05012 | 0.41601933 |
| 128 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.41542018 |
| 129 | Tight junction_Homo sapiens_hsa04530 | 0.40758800 |
| 130 | Thyroid cancer_Homo sapiens_hsa05216 | 0.40492292 |
| 131 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.39924595 |
| 132 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.39667330 |
| 133 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.39481044 |
| 134 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.38808321 |
| 135 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.37598496 |
| 136 | Metabolic pathways_Homo sapiens_hsa01100 | 0.37009913 |
| 137 | Legionellosis_Homo sapiens_hsa05134 | 0.36849876 |
| 138 | Glioma_Homo sapiens_hsa05214 | 0.35739997 |
| 139 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.35640289 |
| 140 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.35399922 |
| 141 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.34645638 |
| 142 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.34630890 |
| 143 | Endometrial cancer_Homo sapiens_hsa05213 | 0.33244277 |
| 144 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.31438646 |
| 145 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.31040969 |
| 146 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.30716023 |
| 147 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.30278769 |
| 148 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.29113532 |
| 149 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.28231205 |
| 150 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.27527123 |
| 151 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.26604266 |
| 152 | Apoptosis_Homo sapiens_hsa04210 | 0.25990654 |
| 153 | Colorectal cancer_Homo sapiens_hsa05210 | 0.25659397 |
| 154 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.24871645 |
| 155 | Salmonella infection_Homo sapiens_hsa05132 | 0.24723880 |
| 156 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.24182253 |
| 157 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.23109603 |

